The Center for Precision Imaging at the Massachusetts General Hospital Martinos
Center/Harvard Medical School has openings for highly qualified individuals at the postdoctoral
level with strong imaging backgrounds to work on PET molecular imaging
projects. Our Center is at the forefront of personalized PET molecular imaging and we
are working to pioneer novel precision imaging and therapy approaches. We have a
long-standing interest in developing and translating targeted biological PET probes for
improved tumor characterization for personalizing cancer treatment and autoimmune
conditions. Over the past decade, we have produced many PET and optical imaging
probes for assessing immune system activation, receptor imaging, imaging of the tumor
microenvironment and interrogation of metabolome. Our group has led some of the first
efforts to diagnose therapeutic resistance through receptor imaging and feedback loop
signaling, monitor and predict the immune response in cancer immunotherapy and
utilize targeted imaging to determine effective therapy dosing, among others. These
efforts have led to two first-in-human imaging agents, most recently 68Ga-NOTA-hGZP
for imaging granzyme B, currently in open trials for clinical validation.
We are seeking candidates for a postdoctoral fellowship focusing on the applications of
PET imaging agents and targeted radiotherapeutics while working closely with a team
of experts in molecular cancer imaging, molecular biology, immuno-oncology,
interventional oncology, and radioligand therapy.

Successful candidate(s) should have a proven track record of continued achievement
and be self-motivated with a strong work ethic, a commitment to teamwork and
effective communication skills. If you are interested, please contact the CPI
sending email to umahmood@mgh.harvard.edu or applying here.

Background in small animal PET image acquisition and analysi
Basic radiometal labeling, kinetic modeling and/or working with animal
models. Prior experience in basic laboratory techniques such as cell culture, Western
blot, and immunofluorescence is preferred.

Minimum requirement is a PhD or MD.